The End of the Beginning

Michael Kinch

£19.99

We send all orders via Royal Mail: within the UK, choose from 1st Class, 2nd Class or Special Delivery; for the rest of the world, International Standard or International Tracked. Delivery and packaging charges are calculated automatically at the checkout.

To collect orders in person from the Bookshop, choose Click and Collect at the checkout.


Pegasus Books
3 April 2019
ISBN: 9781643130255
Hardback
320 pages

From the publisher

For the first time since a 5th century Greek physician gave the name "cancer" (karkinos, in Greek) to a deadly disease first described in Egyptian Papyri, the medical world is near a breakthrough that could allow even the most conservative doctors and pragmatic patients to use the other "c word" - cure - in the same sentence as cancer. A remarkable series of events has brought us to this point, thanks in large part to a new ability to more efficiently harness the extraordinary power of the human immune. The End of the Beginning is a remarkable history of cancer treatment and the evolution of our understanding of its dynamic interplay with the immune system. Through Michael Kinch's personal experience as a cancer researcher at Washington University and the head of the oncology programme at a leading biotechnology company, we witness the incredible accumulation of breakthrough science and its rapid translation into life-saving technologies that have begun to dramatically increase the quality and quantity of life for cancer patients. Expanding upon Kinch's own remarkable projects to encompass the vaccines being deployed to eliminate cervical cancer, the development of cancer-specific "smart bombs" in the form of monoclonal antibodies, cellular therapies and checkpoint inhibitors-The End of the Beginning reveals the incredible transformation of cancer treatment happening today. Kinch details the remarkable history of people, science, technology and disease and presents thrilling next-generation technologies that hold the promise to eliminate cancer for some, and perhaps ultimately, for all.